Peter Ganly

9.4k total citations
58 papers, 1.9k citations indexed

About

Peter Ganly is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Peter Ganly has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 23 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Peter Ganly's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (10 papers). Peter Ganly is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (10 papers). Peter Ganly collaborates with scholars based in New Zealand, United Kingdom and United States. Peter Ganly's co-authors include R.M. Rudd, P S Hasleton, Pamela Rabbitts, V. Sundaresan, N. M. Bleehen, P.H. Rabbitts, G Sinha, Christine M. Morris, Logan C. Walker and John Catalano and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Peter Ganly

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Ganly New Zealand 19 823 798 550 467 306 58 1.9k
Roberto Cairoli Italy 22 725 0.9× 1.1k 1.4× 703 1.3× 446 1.0× 302 1.0× 130 2.1k
Pietro Muretto Italy 27 1.1k 1.4× 1.1k 1.4× 528 1.0× 222 0.5× 634 2.1× 77 2.8k
Chan‐Jeoung Park South Korea 26 502 0.6× 1.2k 1.5× 571 1.0× 233 0.5× 579 1.9× 184 2.4k
Tariq I. Mughal United States 21 788 1.0× 888 1.1× 463 0.8× 182 0.4× 430 1.4× 115 1.7k
Sang Kyun Sohn South Korea 28 567 0.7× 1.4k 1.8× 600 1.1× 391 0.8× 723 2.4× 191 2.7k
Krzysztof Warzocha Poland 26 999 1.2× 614 0.8× 518 0.9× 1.1k 2.4× 672 2.2× 169 2.6k
Argiris Symeonidis Greece 25 908 1.1× 1.6k 2.0× 847 1.5× 364 0.8× 616 2.0× 179 2.4k
Semra Paydaş Türkiye 28 425 0.5× 563 0.7× 627 1.1× 633 1.4× 1.0k 3.4× 208 2.7k
Chul Won Choi South Korea 28 457 0.6× 628 0.8× 487 0.9× 664 1.4× 851 2.8× 192 2.8k
A Najman France 30 940 1.1× 1.6k 2.0× 581 1.1× 421 0.9× 642 2.1× 173 2.8k

Countries citing papers authored by Peter Ganly

Since Specialization
Citations

This map shows the geographic impact of Peter Ganly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ganly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ganly more than expected).

Fields of papers citing papers by Peter Ganly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ganly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ganly. The network helps show where Peter Ganly may publish in the future.

Co-authorship network of co-authors of Peter Ganly

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ganly. A scholar is included among the top collaborators of Peter Ganly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ganly. Peter Ganly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hock, Barry D., et al.. (2018). Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre. Internal Medicine Journal. 49(5). 598–606. 5 indexed citations
2.
Mascarenhas, John, Hilary Blacklock, Aaron T. Gerds, et al.. (2018). Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study. Annals of Hematology. 97(8). 1369–1374. 9 indexed citations
3.
Grigg, A., Belinda Butcher, Ashish Bajel, et al.. (2017). An individualised risk-adapted protocol of pre- and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trial. Bone Marrow Transplantation. 52(9). 1288–1293. 9 indexed citations
4.
Mesa, Ruben A., Miklós Egyed, Anita Szőke, et al.. (2016). Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): 60 week follow-up of the phase III PERSIST-1 trial.. Journal of Clinical Oncology. 34(15_suppl). 7065–7065. 7 indexed citations
5.
Bolli, Niccolò, Vijitha Sathiaseelan, Keiran Raine, et al.. (2016). A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma. Blood Cancer Journal. 6(9). e467–e467. 44 indexed citations
6.
Kim, Dong‐Wook, Shripad Banavali, Udomsak Bunworasate, et al.. (2010). Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era. Leukemia Research. 34(11). 1459–1471. 33 indexed citations
7.
Robak, Tadeusz, Anna Dmoszyńska, Philippe Solal‐Céligny, et al.. (2010). Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 28(10). 1756–1765. 358 indexed citations
8.
Sanders, Joanne M., Alan Pithie, Peter Ganly, et al.. (2008). A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. Journal of Antimicrobial Chemotherapy. 62(4). 809–815. 88 indexed citations
9.
Gough, Sheryl M., et al.. (2006). Translocation (5;10)(q22;q24) in a case of acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 165(1). 36–40. 1 indexed citations
10.
Chambers, Stephen T., Joanne M. Sanders, W. N. Patton, et al.. (2005). Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial. Journal of Hospital Infection. 61(1). 53–61. 43 indexed citations
11.
Ganly, Peter, Logan C. Walker, & Christine M. Morris. (2003). Familial Mutations of the Transcription Factor RUNX1 (AML1, CBFA2) Predispose to Acute Myeloid Leukemia. Leukemia & lymphoma. 45(1). 1–10. 53 indexed citations
12.
13.
Ganly, Peter & Michael Beard. (2001). Osteoclasts in Paget's disease of bone. British Journal of Haematology. 113(2). 259–259. 1 indexed citations
14.
McMullin, Mary Frances, Peter Hillmen, James E. Jackson, Peter Ganly, & Lucio Luzzatto. (1994). Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. Journal of Internal Medicine. 235(1). 85–89. 50 indexed citations
15.
Ganly, Peter, N.A. Jarad, R.M. Rudd, & Pamela Rabbitts. (1992). PCR-based RFLP analysis allows genotyping of the short arm of chromosome 3 in small biopsies from patients with lung cancer. Genomics. 12(2). 221–228. 36 indexed citations
16.
Ganly, Peter & Pamela Rabbitts. (1991). Polymerase chain reaction (PCR) for detection of Mspl polymorphism at the D3S2 locus. Nucleic Acids Research. 19(13). 3761–3761. 8 indexed citations
17.
Ganly, Peter, Jenny Douglas, & Pamela Rabbitts. (1991). Polymerase chain reaction (PCR) for detection of Mspl polymorphism at the D3S6 locus. Nucleic Acids Research. 19(13). 3759–3759. 10 indexed citations
18.
Ganly, Peter & Pamela Rabbitts. (1991). Polymerase chain reaction (PCR) for detection of BamHI polymorphism at the THRB gene. Nucleic Acids Research. 19(13). 3757–3757. 7 indexed citations
19.
Ganly, Peter, et al.. (1988). Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation. Postgraduate Medical Journal. 64(751). 389–391. 16 indexed citations
20.
Ganly, Peter, John D. Isaacs, Michael Laffan, Chris Haslett, & Jill Hows. (1987). Acquired factor VIII inhibitor associated with lung abscess.. BMJ. 295(6602). 811–811. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Cairoli Breakdown of academic impact, for papers by Pietro Muretto Breakdown of academic impact, for papers by Chan‐Jeoung Park Breakdown of academic impact, for papers by Tariq I. Mughal Breakdown of academic impact, for papers by Sang Kyun Sohn Breakdown of academic impact, for papers by Krzysztof Warzocha Breakdown of academic impact, for papers by Argiris Symeonidis Breakdown of academic impact, for papers by Semra Paydaş Breakdown of academic impact, for papers by Chul Won Choi Breakdown of academic impact, for papers by A Najman
Rankless by CCL
2026